Pavmed registers $23 million of common stock for initial units sale

Bookrunner CRT Capital is offering units of common shares and warrants

By Devika Patel

Knoxville, Tenn., April 22 – Pavmed Inc. will price its initial public offering of units of common shares and warrants with a 45-day greenshoe, according to a Form S-1 filed Wednesday with the Securities and Exchange Commission. The company has registered up to $23 million of stock.

CRT Capital is the bookrunner.

Proceeds will be used for research and development, commercialization, licensing and acquisitions, patent prosecutions and intellectual property protection, working capital and general corporate purposes.

The medical device company is based in New York. It expects its shares will trade on the Nasdaq exchange.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.